Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Dermatology

Search Medical Condition
Please enter condition
Please choose location from dropdown

Ichthyosis Clinical Trials

A listing of Ichthyosis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (18) clinical trials

Are you Living with Sjögren’s Syndrome? Sjögren’s syndrome is a condition that causes the body's immune system to attack its own healthy cells. This can result in painfully dry eyes and mouth, swollen joints and skin rashes. It can also affect organs like the kidneys, liver, or lungs.  Sjögren’s syndrome ...

Phase N/A

A Study of Probiotics in IBS Subjects

This study aims to determine the effect of probiotics, as the investigational products (IPs) in subjects satisfying the Rome IV criteria for IBS. Three hundred and sixty six subjects between 18 to 70 years of age and with a positive diagnosis of Rome IV IBS criteria (IBS-C, D, M and ...

Phase N/A

Studies of Skin Microbes in Healthy People and in People With Skin Conditions

Skin microbiota (bacteria, fungi, viruses, phage, archae) play a significant role in common dermatological conditions, such as atopic dermatitis/AD (eczema). Since culture-dependent methods are often biased assessments of microbial diversity, genomic methods can expand our understanding of the human microbiome and skin diseases. Chronic dermatitis is typical among rare primary ...

Phase N/A

Ophthalmological Abnormalities in Hereditary Ichthyosis (ICHTYO-KERATO)

Background: Hereditary ichthyosis are rare genetic diseases characterized by an abnormal epithelial keratinization due to mutations in gene involved in skin barrier. Patients present with scales on the whole body. Recent classification basically distinguishes syndromic from non-syndromic forms. Ichthyoses are severe diseases with significant impact on quality of life, due ...

Phase N/A

Defining the Skin and Blood Biomarkers of Ichthyosis

Objectives To define a panel of skin and blood biomarkers associated with disease activity and pruritus in Netherton syndrome, lamellar ichthyosis, and other ichthyosis subtypes. To determine if blood samples can serve as surrogates for skin immune activation and will correlate with disease severity. To determine FLG, SPINK5, TGM1, or ...

Phase N/A

Fecal Bile Acids Fecal Short Chain Fatty Acids and the Intestinal Microbioita in Patients With IBS and Control Volunteers

There is emerging evidence that alterations in bile acids and SCFA associated with IBS could be associated with changes in the gut microbiota. In addition to modulating levels of intraluminal organic acids, it has been hypothesized that gut microbiota may alter local immune responses, modulate visceral pain responses, and impair ...

Phase N/A

A Six Week Topical Cream Study for Subjects With Ichthyosis Vulgaris

The objective of this study is to determine and compare the safety and efficacy of topical 146-9251 cream and vehicle cream applied twice daily for 6 weeks in subjects with moderate to severe ichthyosis vulgaris (IV).

Phase

The Efficacy and Safety of Secukinumab in Patients With Ichthyoses

The ichthyoses are a group of lifelong genetic disorders which share characteristics of generalized skin thickening, scaling and underlying cutaneous inflammation. The vast majority are orphan disorders and are associated with extremely poor quality of life related to social ostracism from altered appearance, associated itchiness and discomfort, and functional limitations ...

Phase

Gene Therapy for Netherton Syndrome

Netherton Syndrome is a serious skin disorder caused by damage in a gene called SPINK5. This gene controls the formation of a protein called LEKTI, which important for skin barrier function. LEKTI inhibits certain enzymes (serine proteinases) in the outermost layer of the skin (epidermis). The function of the serine ...

Phase

Integrative Approaches to Managing Irritable Bowel Syndrome (IBS)

This project will test the effectiveness of an integrative medicine approach in treating irritable bowel syndrome (IBS). Over the course of 18 months, we will recruit 85 participants with IBS in New York City. These participants will be randomized to either a 4-week group-oriented treatment intervention incorporating a low FODMAP ...

Phase N/A